Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Grant or award EVP, Chief Scientific Officer acquired 9,084 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 4,471 shares (grant or award)
  3. 4 Grant or award CEO acquired 36,477 shares (grant or award)
  4. 4 Open-market sale EVP/Chief Medical Officer sold 1,568 shares at $38.33 ($60,101)
  5. 4 Open-market sale EVP, Chief Business Officer sold 287 shares at $40.61 ($11,655)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale CEO sold 13,805 shares at $38.03 ($525,033)
  9. 4 Grant or award CEO acquired 36,478 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $60.00 ($150,000)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $50.00 ($125,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award EVP, Chief Scientific Officer acquired 32,701 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 18 · 351 filings